Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies
Jangampalli Adi Pradeepkiran, P. Hemachandra Reddy
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1867, Iss. 8, pp. 166162-166162
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy
Yingxu Fang, Jiaxing Wang, Min Zhao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11454-11477
Closed Access | Times Cited: 49
Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease
Jangampalli Adi Pradeepkiran, Javaria Baig, Md Ariful Islam, et al.
Aging and Disease (2024)
Open Access | Times Cited: 14
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy
Jinwang Ye, Hua-Li Wan, Sihua Chen, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1489-1498
Open Access | Times Cited: 22
Selective degradation of hyperphosphorylated tau by proteolysis-targeting chimeras ameliorates cognitive function in Alzheimer’s disease model mice
Dongping Yao, Ting Li, Lu Yu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Small-molecule drugs development for Alzheimer's disease
Weiwei Yao, Huihui Yang, Jinfei Yang
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 23
Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer’s Disease
Devyani Bhatnagar, Shreya Ladhe, Dileep Kumar
Molecular Neurobiology (2023) Vol. 60, Iss. 10, pp. 5954-5974
Closed Access | Times Cited: 16
A review on cyclin-dependent kinase 5: An emerging drug target for neurodegenerative diseases
Shivani Batra, Shagufta Jahan, Anam Ashraf, et al.
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123259-123259
Closed Access | Times Cited: 13
In Silico Drug Design and Analysis of Dual Amyloid-Beta and Tau Protein-Aggregation Inhibitors for Alzheimer’s Disease Treatment
Nisha Job, Venkatesan S. Thimmakondu, Krishnan Thirumoorthy
Molecules (2023) Vol. 28, Iss. 3, pp. 1388-1388
Open Access | Times Cited: 11
Tripartite Motif Protein Family in Central Nervous System Diseases
Mengtian Pan, Xiang Li, Guangchen Xu, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2567-2589
Closed Access | Times Cited: 11
Diagnostics of Alzheimer’s disease using fluorescent nanodiamond-based spin-enhanced lateral flow immunoassay
Wesley Wei‐Wen Hsiao, Stefanny Angela, Trong‐Nghia Le, et al.
Microchemical Journal (2024) Vol. 205, pp. 111315-111315
Closed Access | Times Cited: 4
Experimental basis for generating nonhuman primate models of frontotemporal dementia and Alzheimer's disease
T Morito, Naoto Watamura, Hiroki Sasaguri, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Role of Tau Protein Hyperphosphorylation in Diabetic Retinal Neurodegeneration
Jingyu Mu, Zengrui Zhang, Chao Jiang, et al.
Journal of Ophthalmology (2025) Vol. 2025, Iss. 1
Open Access
Human MAPT knockin mouse models of frontotemporal dementia for the neurodegenerative research community
T Morito, Meng Qi, Naoko Kamano, et al.
Cell Reports Methods (2025), pp. 101024-101024
Open Access
The Emerging Roles of E3 Ligases and DUBs in Neurodegenerative Diseases
Na Liu, Miaomiao Lin, Yan Wang
Molecular Neurobiology (2022) Vol. 60, Iss. 1, pp. 247-263
Open Access | Times Cited: 16
Targeted protein degradation for the treatment of Parkinson’s disease: Advances and future perspective
Roshanak Amirian, Mehdi Azadi Badrbani, Hossein Derakhshankhah, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115408-115408
Open Access | Times Cited: 9
Targeted protein modification as a paradigm shift in drug discovery
Roshanak Amirian, Mehdi Azadi Badrbani, Zhila Izadi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115765-115765
Closed Access | Times Cited: 9
Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer’s Disease
Shiveena Bhatia, Manjinder Singh, Tanveer Singh, et al.
Neurochemical Research (2022) Vol. 48, Iss. 1, pp. 13-25
Closed Access | Times Cited: 15
Cellular response to β‐amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics
Haolin Zhang, Xianghua Li, Xiaoli Wang, et al.
Animal Models and Experimental Medicine (2023) Vol. 6, Iss. 1, pp. 3-9
Open Access | Times Cited: 8
Protective effects of a small molecule inhibitor ligand against hyperphosphorylated tau-induced mitochondrial and synaptic toxicities in Alzheimer disease
Jangampalli Adi Pradeepkiran, Manne Munikumar, Arubala P. Reddy, et al.
Human Molecular Genetics (2021) Vol. 31, Iss. 2, pp. 244-261
Open Access | Times Cited: 19
RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
Sanjay Awasthi, Ashly Hindle, Neha Sawant, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3113-3113
Open Access | Times Cited: 19
Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer’s disease
Mahaveer Singh, Haider Ali, S. Renuka Jyothi, et al.
Brain Research (2024) Vol. 1844, pp. 149165-149165
Closed Access | Times Cited: 2
HMGCS2-Induced Autophagic Degradation of Tau Involves Ketone Body and ANKRD24
Li‐Tian Hu, Xiao‐Yong Xie, Gui‐Feng Zhou, et al.
Journal of Alzheimer s Disease (2022) Vol. 91, Iss. 1, pp. 407-426
Closed Access | Times Cited: 9
Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer’s Disease
Laura Gil, Sandra A. Niño, Carmen Guerrero, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10283-10283
Open Access | Times Cited: 12
Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics
Alba Espargaró, Raimon Sabaté
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 966-968
Open Access | Times Cited: 4
Single MAPT knock-in mouse models of frontotemporal dementia for sharing with the neurodegenerative research community
T Morito, Meng Qi, Naoko Kamano, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top